Camurus’ Interim Report January-March 2023
“A strong quarter with solid organic growth, both top and bottom line” Summary first quarter 2023 January – March · Total revenues amounted to SEK 284 (220) million, an increase of 29% (24% at CER[1]), whereof product sales were SEK 282 (202) million, an increase of 40% (35% at CER[1]) · Revenue and product sales increased 6% compared to previous quarter · Operating result was SEK 74 (5) million, an increase of SEK 69 million · Cash position at the end of the quarter was SEK 586 (400) million, an increase of SEK 186 million (47%) · Number of patients treated with